Inactive Instrument

Other languages Vical Incorporated Nasdaq

Equities

US9256022032

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15
Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	23-09-20
US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	23-09-20
Top Premarket Gainers	23-09-20
Fresh Tracks Therapeutics' Board Approves Liquidation Plan; Shares Rise After Hours	23-09-19
Fresh Tracks Therapeutics, Inc. Announces Chief Executive Officer Changes	23-09-19
Fresh Tracks Therapeutics, Inc. Announces Executive Changes	23-09-19
Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11
Fresh Tracks Therapeutics, Inc. Announces Resignation of Robert B. Brown from the Board of Directors, Effective Immediately	23-07-25
Wall Street Set to Open Higher, Investors Look to End Week on Positive Note	23-07-21
Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Fresh Tracks Therapeutics, Inc. Announces Resignation of Gary A. Lyons from the Board of Directors	23-04-27
Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30
Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-30
MÄRKTE USA/Uneinheitlich - Zinspfad ungewiss	23-03-08
MÄRKTE USA/Uneinheitlich - Zinssorgen bleiben präsent	23-03-08
MÄRKTE USA/Wall Street mit leichter Erholung	23-03-08
MÄRKTE USA/Wall Street stabilisiert nach Vortagesverlusten	23-03-08
Investors Cautious Ahead of More Powell Testimony, Stifling US Equity Futures	23-03-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Vical Incorporated Nasdaq

Equities

US9256022032

Other languages

Filters